This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Clinical Efficacy and Safety of MB LuxuryⓇ Product Containing Epigallocathecin Gallate (EGCG) on Erythema, Melanin, and Skin Hydration | MicrobiomeTrials
← Back to trials NCT07725900
Clinical Efficacy and Safety of MB LuxuryⓇ Product Containing Epigallocathecin Gallate (EGCG) on Erythema, Melanin, and Skin Hydration Completed PHASE2, PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2025-12-01Est. Completion: 2026-03-01
Enrollment target: 300 participantsLocations Universitas Islam Sultan Agung, Semarang, Central Java, Indonesia Other microbiome trials you might be interested in Melasma
The goal of this clinical trial is to learn whether a topical formulation containing 12% azelaic acid and 5% tranexamic …
Tijuana, Mexico Completed Jul 10, 2026
Cushing's Syndrome Pituitary Adenoma Carney Complex Primary Pigmented Nodular Adrenocortical Disease Peutz-Jeghers Syndrome
Lentiginosis refers to groups of diseases marked by the presence of pigmented spots on the skin. These conditions are mo…
Bethesda, United States